Advertisement
Australia markets close in 5 hours 9 minutes
  • ALL ORDS

    7,824.90
    -74.00 (-0.94%)
     
  • ASX 200

    7,567.70
    -74.40 (-0.97%)
     
  • AUD/USD

    0.6410
    -0.0015 (-0.24%)
     
  • OIL

    82.60
    -0.13 (-0.16%)
     
  • GOLD

    2,392.40
    -5.60 (-0.23%)
     
  • Bitcoin AUD

    97,889.31
    +1,881.41 (+1.96%)
     
  • CMC Crypto 200

    1,304.59
    +419.05 (+46.96%)
     
  • AUD/EUR

    0.6023
    -0.0008 (-0.13%)
     
  • AUD/NZD

    1.0868
    -0.0007 (-0.07%)
     
  • NZX 50

    11,813.35
    -22.69 (-0.19%)
     
  • NASDAQ

    17,394.31
    -99.31 (-0.57%)
     
  • FTSE

    7,877.05
    +29.06 (+0.37%)
     
  • Dow Jones

    37,775.38
    +22.07 (+0.06%)
     
  • DAX

    17,837.40
    +67.38 (+0.38%)
     
  • Hang Seng

    16,385.87
    +134.03 (+0.82%)
     
  • NIKKEI 225

    37,307.48
    -772.22 (-2.03%)
     

Cancer drug key to $21bln pharma deal

AbbVie is to buy Pharmacyclics Inc for about $21 billion. As Hayley Platt reports it continues a growing M&A trend in the sector and will give the drugmaker access to what is expected to be one of the world's top-selling cancer drugs.